

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 6.55490214 |
| 2 | cardiac myofibril assembly (GO:0055003) | 5.88501194 |
| 3 | myofibril assembly (GO:0030239) | 5.59852611 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.57156936 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.52334501 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.45137257 |
| 7 | plasma membrane repair (GO:0001778) | 5.42167675 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.41620192 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.34269833 |
| 10 | actin-myosin filament sliding (GO:0033275) | 5.33600831 |
| 11 | muscle filament sliding (GO:0030049) | 5.33600831 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.21928004 |
| 13 | cardiac muscle contraction (GO:0060048) | 5.12314784 |
| 14 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.82823970 |
| 15 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.80786176 |
| 16 | response to muscle activity (GO:0014850) | 4.76003751 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.74155081 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 4.64037151 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.59943809 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 4.59033522 |
| 21 | detection of calcium ion (GO:0005513) | 4.58792923 |
| 22 | skeletal muscle fiber development (GO:0048741) | 4.41982781 |
| 23 | actin-mediated cell contraction (GO:0070252) | 4.38554914 |
| 24 | regulation of membrane repolarization (GO:0060306) | 4.38492598 |
| 25 | regulation of actin filament-based movement (GO:1903115) | 4.36349942 |
| 26 | striated muscle contraction (GO:0006941) | 4.34395917 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.28127421 |
| 28 | myotube cell development (GO:0014904) | 4.26953413 |
| 29 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.25497920 |
| 30 | actomyosin structure organization (GO:0031032) | 4.25280166 |
| 31 | glycogen catabolic process (GO:0005980) | 4.19409674 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.17132320 |
| 33 | cardiac muscle cell development (GO:0055013) | 4.08823257 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 4.07614143 |
| 35 | cell communication by electrical coupling (GO:0010644) | 4.07321891 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.04025823 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 3.98635775 |
| 38 | glucan catabolic process (GO:0009251) | 3.84572384 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 3.81479680 |
| 40 | carnitine shuttle (GO:0006853) | 3.81196602 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 3.81148104 |
| 42 | relaxation of cardiac muscle (GO:0055119) | 3.80777666 |
| 43 | cardiac cell development (GO:0055006) | 3.78791245 |
| 44 | adult heart development (GO:0007512) | 3.78232688 |
| 45 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.76410270 |
| 46 | glycogen biosynthetic process (GO:0005978) | 3.74350227 |
| 47 | glucan biosynthetic process (GO:0009250) | 3.74350227 |
| 48 | muscle fiber development (GO:0048747) | 3.73057950 |
| 49 | striated muscle hypertrophy (GO:0014897) | 3.67017735 |
| 50 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.65614768 |
| 51 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.61856131 |
| 52 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.61458153 |
| 53 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.61458153 |
| 54 | regulation of sarcomere organization (GO:0060297) | 3.57899891 |
| 55 | regulation of glucokinase activity (GO:0033131) | 3.56091298 |
| 56 | regulation of hexokinase activity (GO:1903299) | 3.56091298 |
| 57 | cellular polysaccharide catabolic process (GO:0044247) | 3.55119944 |
| 58 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.53090316 |
| 59 | neuromuscular synaptic transmission (GO:0007274) | 3.51164819 |
| 60 | heart process (GO:0003015) | 3.50924057 |
| 61 | heart contraction (GO:0060047) | 3.50924057 |
| 62 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.49006226 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 3.48701173 |
| 64 | heart trabecula formation (GO:0060347) | 3.46852482 |
| 65 | cardiac conduction (GO:0061337) | 3.46070242 |
| 66 | NADH metabolic process (GO:0006734) | 3.44370786 |
| 67 | negative regulation of potassium ion transport (GO:0043267) | 3.44311857 |
| 68 | skeletal muscle contraction (GO:0003009) | 3.41847049 |
| 69 | muscle cell cellular homeostasis (GO:0046716) | 3.41794107 |
| 70 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.35023405 |
| 71 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.34362335 |
| 72 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.32502502 |
| 73 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.31473677 |
| 74 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.29620581 |
| 75 | striated muscle adaptation (GO:0014888) | 3.26512243 |
| 76 | actin filament-based movement (GO:0030048) | 3.25146914 |
| 77 | cardiac muscle cell action potential (GO:0086001) | 3.24809310 |
| 78 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.23875438 |
| 79 | regulation of heart rate (GO:0002027) | 3.23473159 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 3.23300969 |
| 81 | COPI coating of Golgi vesicle (GO:0048205) | 3.23300969 |
| 82 | membrane repolarization during action potential (GO:0086011) | 3.20510977 |
| 83 | regulation of cardiac muscle contraction (GO:0055117) | 3.20209522 |
| 84 | regulation of cofactor metabolic process (GO:0051193) | 3.19414937 |
| 85 | regulation of coenzyme metabolic process (GO:0051196) | 3.19414937 |
| 86 | polysaccharide catabolic process (GO:0000272) | 3.16445681 |
| 87 | ubiquinone biosynthetic process (GO:0006744) | 3.15937176 |
| 88 | muscle tissue morphogenesis (GO:0060415) | 3.14979618 |
| 89 | creatine metabolic process (GO:0006600) | 3.14088450 |
| 90 | muscle hypertrophy (GO:0014896) | 3.13900972 |
| 91 | fatty acid transmembrane transport (GO:1902001) | 3.10003925 |
| 92 | skeletal muscle tissue development (GO:0007519) | 3.08487773 |
| 93 | activation of protein kinase A activity (GO:0034199) | 3.08052647 |
| 94 | gluconeogenesis (GO:0006094) | 3.06456275 |
| 95 | regulation of heart contraction (GO:0008016) | 3.05353816 |
| 96 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.05282034 |
| 97 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.05282034 |
| 98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.05207873 |
| 99 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.05200539 |
| 100 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02458253 |
| 101 | growth hormone secretion (GO:0030252) | 3.02020909 |
| 102 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01441903 |
| 103 | muscle contraction (GO:0006936) | 3.00019690 |
| 104 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.99101971 |
| 105 | glycogen metabolic process (GO:0005977) | 2.99012300 |
| 106 | fructose metabolic process (GO:0006000) | 2.97911616 |
| 107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.97125062 |
| 108 | muscle hypertrophy in response to stress (GO:0003299) | 2.97125062 |
| 109 | cardiac muscle adaptation (GO:0014887) | 2.97125062 |
| 110 | calcium ion import (GO:0070509) | 2.95062704 |
| 111 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93250837 |
| 112 | response to inactivity (GO:0014854) | 2.91765984 |
| 113 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.90927138 |
| 114 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.90181358 |
| 115 | cellular glucan metabolic process (GO:0006073) | 2.89987114 |
| 116 | glucan metabolic process (GO:0044042) | 2.89987114 |
| 117 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.89413448 |
| 118 | relaxation of muscle (GO:0090075) | 2.87433492 |
| 119 | succinate metabolic process (GO:0006105) | 2.87053587 |
| 120 | regulation of ATPase activity (GO:0043462) | 2.86848032 |
| 121 | regulation of ATP catabolic process (GO:1903289) | 2.86848032 |
| 122 | * positive regulation of cation channel activity (GO:2001259) | 2.85166645 |
| 123 | membrane repolarization (GO:0086009) | 2.84757483 |
| 124 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.84388506 |
| 125 | positive regulation of potassium ion transport (GO:0043268) | 2.83834961 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.83460611 |
| 127 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.82814390 |
| 128 | muscle system process (GO:0003012) | 2.82506407 |
| 129 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82373570 |
| 130 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.82102990 |
| 131 | positive regulation of heart rate (GO:0010460) | 2.81975133 |
| 132 | muscle organ development (GO:0007517) | 2.81394166 |
| 133 | skeletal muscle adaptation (GO:0043501) | 2.81380649 |
| 134 | muscle structure development (GO:0061061) | 2.81245893 |
| 135 | aspartate family amino acid catabolic process (GO:0009068) | 2.80983882 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.79238293 |
| 137 | striated muscle cell development (GO:0055002) | 2.78719788 |
| 138 | ubiquinone metabolic process (GO:0006743) | 2.77929330 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.77465932 |
| 140 | hexose biosynthetic process (GO:0019319) | 2.73603638 |
| 141 | positive regulation of sodium ion transport (GO:0010765) | 2.72484835 |
| 142 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.72004886 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 2.71555675 |
| 144 | proline transport (GO:0015824) | 2.68920754 |
| 145 | muscle cell fate commitment (GO:0042693) | 2.65216213 |
| 146 | muscle organ morphogenesis (GO:0048644) | 2.61045427 |
| 147 | positive regulation of synapse maturation (GO:0090129) | 2.60212629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.90925714 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.77499480 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.73549811 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.61040276 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55378006 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49643779 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20389411 |
| 8 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.19450648 |
| 9 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.19450648 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14887136 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.12849587 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.07661080 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.03832378 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97582814 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92344145 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91555364 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88703090 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.86800161 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85376780 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82460666 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80521765 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80145543 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78968217 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74398641 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74398641 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.74009017 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71716433 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71688080 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.68188242 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67492012 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66080318 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.65056231 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63597583 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.63449365 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54965609 |
| 36 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.54578593 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53995886 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53102133 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.53092079 |
| 40 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52300256 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51165375 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48242606 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45646859 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43564289 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40251877 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38078314 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36141503 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35212070 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32254840 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29169261 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28305604 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27402282 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25240274 |
| 54 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23919399 |
| 55 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.23736047 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22307982 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21544372 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20982186 |
| 59 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20937608 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20317404 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20181283 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18892577 |
| 63 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18648521 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18273417 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14619507 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11757055 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.11673770 |
| 68 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09465571 |
| 69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09189773 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09189773 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06796882 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06365391 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05298084 |
| 74 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04693677 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04302348 |
| 76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02884900 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02871362 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02813110 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02672439 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02591452 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02501807 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02152785 |
| 83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02067478 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01736521 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01350732 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00679563 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98503500 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98503500 |
| 89 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.98378779 |
| 90 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97688637 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97627885 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97606702 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97230314 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97132358 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97059539 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96847277 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96438388 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96377718 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95715447 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95521712 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95405167 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95223372 |
| 103 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94821548 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93850080 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93792117 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91835992 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91499788 |
| 108 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90868469 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90258333 |
| 110 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89890195 |
| 111 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89871456 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89806225 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89712583 |
| 114 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89681135 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89579903 |
| 116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88824967 |
| 117 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88680376 |
| 118 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88609541 |
| 119 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88357144 |
| 120 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88182075 |
| 121 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88125726 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87812774 |
| 123 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87194741 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86845623 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86687008 |
| 126 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.85593323 |
| 127 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85313523 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85256238 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85180017 |
| 130 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.84948826 |
| 131 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84510087 |
| 132 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84143583 |
| 133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84104541 |
| 134 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.83958412 |
| 135 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83662866 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83541104 |
| 137 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83515371 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83272421 |
| 139 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82261496 |
| 140 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.82150779 |
| 141 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.81341709 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80703063 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80597875 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80118034 |
| 145 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79165179 |
| 146 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79159486 |
| 147 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79111975 |
| 148 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78683351 |
| 149 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78533295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.63132549 |
| 2 | MP0003646_muscle_fatigue | 4.73276777 |
| 3 | MP0000751_myopathy | 4.51140483 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.30863239 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.85394563 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.85152075 |
| 7 | MP0000749_muscle_degeneration | 3.62116879 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.35157077 |
| 9 | MP0005330_cardiomyopathy | 2.82329432 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.53406632 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.51689464 |
| 12 | MP0002972_abnormal_cardiac_muscle | 2.44226831 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.41145301 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.33297306 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.31831774 |
| 16 | MP0004130_abnormal_muscle_cell | 2.31210444 |
| 17 | MP0002269_muscular_atrophy | 2.27813086 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.22841149 |
| 19 | MP0000747_muscle_weakness | 2.15268717 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.13680849 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.03303012 |
| 22 | MP0008775_abnormal_heart_ventricle | 2.03227604 |
| 23 | MP0004043_abnormal_pH_regulation | 2.02135988 |
| 24 | MP0004085_abnormal_heartbeat | 1.99016365 |
| 25 | MP0004484_altered_response_of | 1.95866025 |
| 26 | MP0005369_muscle_phenotype | 1.94245381 |
| 27 | MP0000759_abnormal_skeletal_muscle | 1.91346082 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.90139155 |
| 29 | MP0005451_abnormal_body_composition | 1.80661869 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.80147848 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.80147848 |
| 32 | MP0004233_abnormal_muscle_weight | 1.79549433 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.74301594 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.73819565 |
| 35 | MP0003787_abnormal_imprinting | 1.73613644 |
| 36 | MP0003283_abnormal_digestive_organ | 1.70291886 |
| 37 | MP0006138_congestive_heart_failure | 1.67485856 |
| 38 | MP0004270_analgesia | 1.65672344 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.62802867 |
| 40 | MP0004510_myositis | 1.56652577 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.44342881 |
| 42 | * MP0002693_abnormal_pancreas_physiology | 1.41128162 |
| 43 | MP0003195_calcinosis | 1.33971349 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.28714039 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.27973857 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.27264976 |
| 47 | MP0003123_paternal_imprinting | 1.27133966 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25737417 |
| 49 | * MP0002078_abnormal_glucose_homeostasis | 1.24830450 |
| 50 | MP0002822_catalepsy | 1.22001285 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.21827978 |
| 52 | MP0002127_abnormal_cardiovascular_syste | 1.21238030 |
| 53 | MP0000733_abnormal_muscle_development | 1.19466927 |
| 54 | MP0003828_pulmonary_edema | 1.18399236 |
| 55 | MP0001984_abnormal_olfaction | 1.17603416 |
| 56 | MP0001944_abnormal_pancreas_morphology | 1.15366715 |
| 57 | MP0005375_adipose_tissue_phenotype | 1.12382237 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.11237085 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.09838377 |
| 60 | MP0001529_abnormal_vocalization | 1.09336934 |
| 61 | MP0001486_abnormal_startle_reflex | 1.05504580 |
| 62 | MP0005670_abnormal_white_adipose | 1.05395011 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.04883521 |
| 64 | MP0004147_increased_porphyrin_level | 1.04156210 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.02087985 |
| 66 | MP0001501_abnormal_sleep_pattern | 0.96963606 |
| 67 | MP0004142_abnormal_muscle_tone | 0.95009308 |
| 68 | MP0006276_abnormal_autonomic_nervous | 0.93471188 |
| 69 | MP0008569_lethality_at_weaning | 0.91835225 |
| 70 | MP0000678_abnormal_parathyroid_gland | 0.91229585 |
| 71 | MP0005535_abnormal_body_temperature | 0.91001515 |
| 72 | MP0009745_abnormal_behavioral_response | 0.90758695 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 0.90018828 |
| 74 | MP0002108_abnormal_muscle_morphology | 0.88670447 |
| 75 | MP0003880_abnormal_central_pattern | 0.87830464 |
| 76 | MP0001661_extended_life_span | 0.87404582 |
| 77 | MP0002063_abnormal_learning/memory/cond | 0.86780619 |
| 78 | * MP0000230_abnormal_systemic_arterial | 0.84319430 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.83753135 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 0.82976602 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.82493886 |
| 82 | MP0002064_seizures | 0.82362317 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.82307661 |
| 84 | * MP0002272_abnormal_nervous_system | 0.79772991 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.78235869 |
| 86 | MP0004924_abnormal_behavior | 0.77825617 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.77825617 |
| 88 | MP0000266_abnormal_heart_morphology | 0.76901300 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.76773857 |
| 90 | MP0005187_abnormal_penis_morphology | 0.76162124 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.76129180 |
| 92 | MP0008872_abnormal_physiological_respon | 0.76032317 |
| 93 | MP0009046_muscle_twitch | 0.75219964 |
| 94 | MP0005165_increased_susceptibility_to | 0.74696917 |
| 95 | MP0002572_abnormal_emotion/affect_behav | 0.74042738 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.73792029 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.73149366 |
| 98 | MP0003122_maternal_imprinting | 0.70115962 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.69597728 |
| 100 | MP0002557_abnormal_social/conspecific_i | 0.68520725 |
| 101 | MP0005332_abnormal_amino_acid | 0.68220183 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.65463195 |
| 103 | MP0002229_neurodegeneration | 0.64704503 |
| 104 | MP0005266_abnormal_metabolism | 0.64702364 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.64556042 |
| 106 | MP0005083_abnormal_biliary_tract | 0.64079689 |
| 107 | MP0004885_abnormal_endolymph | 0.63398309 |
| 108 | MP0003045_fibrosis | 0.62666486 |
| 109 | * MP0003953_abnormal_hormone_level | 0.61157270 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.60420711 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.59727841 |
| 112 | MP0003879_abnormal_hair_cell | 0.59234237 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.57994730 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.57016931 |
| 115 | MP0001970_abnormal_pain_threshold | 0.55548535 |
| 116 | MP0002971_abnormal_brown_adipose | 0.53340079 |
| 117 | MP0003633_abnormal_nervous_system | 0.53015118 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.52918520 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.51084456 |
| 120 | MP0004858_abnormal_nervous_system | 0.50779158 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.50649020 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.49528746 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.49503148 |
| 124 | MP0005645_abnormal_hypothalamus_physiol | 0.49431836 |
| 125 | MP0005448_abnormal_energy_balance | 0.49365871 |
| 126 | MP0003329_amyloid_beta_deposits | 0.48420590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.54563071 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.26554100 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.86148728 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.65669058 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 5.53560426 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.05885290 |
| 7 | Myoglobinuria (HP:0002913) | 4.85735109 |
| 8 | Bundle branch block (HP:0011710) | 4.68476202 |
| 9 | Atrial fibrillation (HP:0005110) | 4.66328390 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.58500414 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.54688719 |
| 12 | Subaortic stenosis (HP:0001682) | 4.54688719 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.52719927 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.38690368 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.37784676 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.17897582 |
| 17 | Syncope (HP:0001279) | 4.15259686 |
| 18 | Prolonged QT interval (HP:0001657) | 4.13300975 |
| 19 | Round ear (HP:0100830) | 4.11186171 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 4.08210612 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.93478812 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.80475917 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.80400153 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.80226950 |
| 25 | Palpitations (HP:0001962) | 3.70344601 |
| 26 | Lipoatrophy (HP:0100578) | 3.67553241 |
| 27 | Myotonia (HP:0002486) | 3.57492324 |
| 28 | Difficulty running (HP:0009046) | 3.56621581 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.51739796 |
| 30 | Heart block (HP:0012722) | 3.47720091 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 3.45740059 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.41491199 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.40533092 |
| 34 | Dilated cardiomyopathy (HP:0001644) | 3.31381480 |
| 35 | Frequent falls (HP:0002359) | 3.28656849 |
| 36 | Abnormal atrioventricular conduction (HP:0005150) | 3.24485101 |
| 37 | Abnormal EKG (HP:0003115) | 3.19646162 |
| 38 | Atrioventricular block (HP:0001678) | 3.14516127 |
| 39 | Increased connective tissue (HP:0009025) | 3.13312758 |
| 40 | Rhabdomyolysis (HP:0003201) | 3.08728038 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.04847855 |
| 42 | Absent phalangeal crease (HP:0006109) | 3.01581479 |
| 43 | Muscle fiber inclusion bodies (HP:0100299) | 3.00527011 |
| 44 | Calcaneovalgus deformity (HP:0001848) | 2.99460103 |
| 45 | * Hyperinsulinemic hypoglycemia (HP:0000825) | 2.99298617 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.94961140 |
| 47 | Left ventricular hypertrophy (HP:0001712) | 2.92906571 |
| 48 | Pheochromocytoma (HP:0002666) | 2.90261170 |
| 49 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.88482793 |
| 50 | * Ketoacidosis (HP:0001993) | 2.87564717 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.84266250 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.76067258 |
| 53 | Deformed tarsal bones (HP:0008119) | 2.70786190 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.69720673 |
| 55 | Malignant hyperthermia (HP:0002047) | 2.66623276 |
| 56 | Muscle stiffness (HP:0003552) | 2.66304272 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.61413992 |
| 58 | Late onset (HP:0003584) | 2.52136876 |
| 59 | Symptomatic seizures (HP:0011145) | 2.51759812 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.50932039 |
| 61 | Testicular atrophy (HP:0000029) | 2.45678969 |
| 62 | Abnormal finger flexion creases (HP:0006143) | 2.43329616 |
| 63 | Generalized muscle weakness (HP:0003324) | 2.42160261 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39706033 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.37760904 |
| 66 | Visual hallucinations (HP:0002367) | 2.32678635 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32146416 |
| 68 | Neck muscle weakness (HP:0000467) | 2.30802375 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27169764 |
| 70 | Nemaline bodies (HP:0003798) | 2.25273654 |
| 71 | * Hyperglycemia (HP:0003074) | 2.24924702 |
| 72 | Hyperkalemia (HP:0002153) | 2.24464193 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.23210282 |
| 74 | Focal motor seizures (HP:0011153) | 2.22473729 |
| 75 | Dysmetric saccades (HP:0000641) | 2.21974308 |
| 76 | Decreased circulating renin level (HP:0003351) | 2.20587390 |
| 77 | Limb-girdle muscle atrophy (HP:0003797) | 2.14349237 |
| 78 | Areflexia of lower limbs (HP:0002522) | 2.11530092 |
| 79 | Hepatic necrosis (HP:0002605) | 2.11467952 |
| 80 | Bulbar palsy (HP:0001283) | 2.10327940 |
| 81 | Weak cry (HP:0001612) | 2.09769575 |
| 82 | Myopathic facies (HP:0002058) | 2.09255957 |
| 83 | * Insulin-resistant diabetes mellitus (HP:0000831) | 2.09246633 |
| 84 | Abnormality of the neuromuscular junction (HP:0003398) | 2.07257304 |
| 85 | Fatigable weakness (HP:0003473) | 2.07257304 |
| 86 | Rimmed vacuoles (HP:0003805) | 2.05350654 |
| 87 | * Large for gestational age (HP:0001520) | 2.02057511 |
| 88 | Proximal amyotrophy (HP:0007126) | 2.00788292 |
| 89 | Central scotoma (HP:0000603) | 2.00019075 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 1.93282297 |
| 91 | Exercise intolerance (HP:0003546) | 1.91276883 |
| 92 | Hypoplastic ischia (HP:0003175) | 1.90596641 |
| 93 | Progressive macrocephaly (HP:0004481) | 1.88717211 |
| 94 | Tinnitus (HP:0000360) | 1.88240446 |
| 95 | Gowers sign (HP:0003391) | 1.87931541 |
| 96 | Acute encephalopathy (HP:0006846) | 1.86943936 |
| 97 | Progressive muscle weakness (HP:0003323) | 1.85812331 |
| 98 | Palmoplantar keratoderma (HP:0000982) | 1.84526353 |
| 99 | Hamartoma of the eye (HP:0010568) | 1.84352850 |
| 100 | Slender build (HP:0001533) | 1.81233977 |
| 101 | Generalized aminoaciduria (HP:0002909) | 1.80012442 |
| 102 | Scapular winging (HP:0003691) | 1.79135547 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 1.78551744 |
| 104 | Muscular dystrophy (HP:0003560) | 1.78361045 |
| 105 | * Ketosis (HP:0001946) | 1.78262828 |
| 106 | Generalized tonic-clonic seizures (HP:0002069) | 1.75743567 |
| 107 | Hip contracture (HP:0003273) | 1.75473133 |
| 108 | Hyperphosphatemia (HP:0002905) | 1.75267993 |
| 109 | Hypokalemia (HP:0002900) | 1.73443289 |
| 110 | Febrile seizures (HP:0002373) | 1.72058616 |
| 111 | Nonprogressive disorder (HP:0003680) | 1.71539936 |
| 112 | Athetosis (HP:0002305) | 1.70710511 |
| 113 | Neoplasm of the adrenal gland (HP:0100631) | 1.70704183 |
| 114 | Conjunctival hamartoma (HP:0100780) | 1.70431744 |
| 115 | Waddling gait (HP:0002515) | 1.70018421 |
| 116 | Anxiety (HP:0000739) | 1.69943412 |
| 117 | Rapidly progressive (HP:0003678) | 1.69671114 |
| 118 | Sudden cardiac death (HP:0001645) | 1.69475738 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.68810994 |
| 120 | Congestive heart failure (HP:0001635) | 1.67460200 |
| 121 | Abnormality of potassium homeostasis (HP:0011042) | 1.66710372 |
| 122 | Distal arthrogryposis (HP:0005684) | 1.66703124 |
| 123 | Ragged-red muscle fibers (HP:0003200) | 1.66542907 |
| 124 | Hepatocellular necrosis (HP:0001404) | 1.66228121 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.65515497 |
| 126 | Increased intramyocellular lipid droplets (HP:0012240) | 1.63193326 |
| 127 | Abnormality of the foot musculature (HP:0001436) | 1.63161263 |
| 128 | Lower limb amyotrophy (HP:0007210) | 1.59832410 |
| 129 | Hyperthyroidism (HP:0000836) | 1.58662905 |
| 130 | Poor eye contact (HP:0000817) | 1.58440968 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.58065044 |
| 132 | Absence seizures (HP:0002121) | 1.57262996 |
| 133 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.57050910 |
| 134 | Increased muscle lipid content (HP:0009058) | 1.49955243 |
| 135 | Foot dorsiflexor weakness (HP:0009027) | 1.49212880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.40930400 |
| 2 | OBSCN | 3.88091523 |
| 3 | PHKG1 | 3.82974570 |
| 4 | PHKG2 | 3.82974570 |
| 5 | INSRR | 3.76236474 |
| 6 | TRIB3 | 2.54205466 |
| 7 | LMTK2 | 2.52322526 |
| 8 | PRKD3 | 2.38508253 |
| 9 | DMPK | 2.35281047 |
| 10 | PDK3 | 2.32706605 |
| 11 | PDK4 | 2.32706605 |
| 12 | NTRK3 | 2.19905742 |
| 13 | PINK1 | 2.12506081 |
| 14 | MYLK | 1.99627670 |
| 15 | PKN2 | 1.95961970 |
| 16 | MUSK | 1.74148748 |
| 17 | NEK1 | 1.60791235 |
| 18 | MAP2K6 | 1.51054572 |
| 19 | PIK3CA | 1.49392779 |
| 20 | MAP3K4 | 1.48085315 |
| 21 | PAK3 | 1.47832673 |
| 22 | EPHA4 | 1.46426980 |
| 23 | CDC42BPA | 1.46068728 |
| 24 | BCKDK | 1.44156268 |
| 25 | WNK4 | 1.35908492 |
| 26 | TRPM7 | 1.29508205 |
| 27 | NME1 | 1.27636500 |
| 28 | MAP3K1 | 1.25391682 |
| 29 | LIMK1 | 1.25240658 |
| 30 | HIPK2 | 1.16178567 |
| 31 | CASK | 1.14174879 |
| 32 | PDK2 | 1.14138011 |
| 33 | PRKD1 | 1.12890002 |
| 34 | PDGFRA | 1.10424401 |
| 35 | PRKCH | 1.09055120 |
| 36 | MAP2K4 | 1.08355482 |
| 37 | TAOK3 | 1.08189830 |
| 38 | TIE1 | 1.05823748 |
| 39 | PASK | 1.05611892 |
| 40 | MAPK13 | 1.03668357 |
| 41 | PRKAA1 | 1.03571606 |
| 42 | RIPK1 | 1.02175373 |
| 43 | UHMK1 | 1.01238572 |
| 44 | MAP3K7 | 1.00829332 |
| 45 | MAP3K2 | 0.96894807 |
| 46 | * CAMK2D | 0.96165290 |
| 47 | STK24 | 0.95386643 |
| 48 | STK38 | 0.94575496 |
| 49 | MAPK15 | 0.93827296 |
| 50 | FLT3 | 0.93718895 |
| 51 | KSR2 | 0.92202334 |
| 52 | PAK6 | 0.89739380 |
| 53 | WNK1 | 0.89488963 |
| 54 | CAMKK2 | 0.88922047 |
| 55 | NTRK1 | 0.88262696 |
| 56 | MAP4K2 | 0.88244500 |
| 57 | DAPK2 | 0.87443499 |
| 58 | CAMKK1 | 0.84934382 |
| 59 | CAMK2A | 0.84574566 |
| 60 | EEF2K | 0.81155032 |
| 61 | BMPR1B | 0.80246528 |
| 62 | RET | 0.77713946 |
| 63 | MAP3K9 | 0.77319661 |
| 64 | PIK3CG | 0.75292746 |
| 65 | GRK7 | 0.73965440 |
| 66 | PRKCE | 0.73850169 |
| 67 | TNK2 | 0.73356055 |
| 68 | FER | 0.71881757 |
| 69 | MAP2K7 | 0.70722879 |
| 70 | FGFR2 | 0.69306161 |
| 71 | CCNB1 | 0.68957545 |
| 72 | AKT2 | 0.68247162 |
| 73 | MAPK12 | 0.65955002 |
| 74 | CAMK1 | 0.65374771 |
| 75 | SGK3 | 0.64089182 |
| 76 | ROCK1 | 0.63962528 |
| 77 | MAP3K5 | 0.63027860 |
| 78 | PDPK1 | 0.62973775 |
| 79 | CAMK4 | 0.62599199 |
| 80 | CSNK1G1 | 0.61215720 |
| 81 | ERBB3 | 0.60106308 |
| 82 | CSNK1G2 | 0.59058659 |
| 83 | PRKAA2 | 0.58625839 |
| 84 | GRK1 | 0.56894687 |
| 85 | CDK5 | 0.56683497 |
| 86 | WNK3 | 0.55911645 |
| 87 | SGK2 | 0.54834071 |
| 88 | SGK1 | 0.54393338 |
| 89 | PDK1 | 0.54159407 |
| 90 | ILK | 0.54078774 |
| 91 | PTK6 | 0.53316075 |
| 92 | CAMK2G | 0.52278893 |
| 93 | TAOK1 | 0.50909369 |
| 94 | CSNK1G3 | 0.50166844 |
| 95 | PRKACG | 0.49714264 |
| 96 | * PRKACA | 0.49543331 |
| 97 | PRKD2 | 0.49075298 |
| 98 | CAMK2B | 0.49039404 |
| 99 | MARK1 | 0.47965942 |
| 100 | SGK223 | 0.47487358 |
| 101 | SGK494 | 0.47487358 |
| 102 | DAPK3 | 0.47215234 |
| 103 | NTRK2 | 0.46457851 |
| 104 | RPS6KA2 | 0.45557656 |
| 105 | ADRBK2 | 0.45422995 |
| 106 | MAP2K3 | 0.45255009 |
| 107 | PKN1 | 0.43613682 |
| 108 | RPS6KA3 | 0.43370070 |
| 109 | RPS6KB1 | 0.41983688 |
| 110 | MAP2K1 | 0.41875555 |
| 111 | GRK5 | 0.41317976 |
| 112 | MARK2 | 0.41214643 |
| 113 | PTK2B | 0.41139883 |
| 114 | MINK1 | 0.40079701 |
| 115 | STK11 | 0.39139058 |
| 116 | TAF1 | 0.38889787 |
| 117 | OXSR1 | 0.38695628 |
| 118 | PRKACB | 0.37717219 |
| 119 | FRK | 0.35697866 |
| 120 | MAPK11 | 0.33174304 |
| 121 | EPHA3 | 0.32860467 |
| 122 | MOS | 0.32078966 |
| 123 | PRKG1 | 0.32054660 |
| 124 | MAPKAPK3 | 0.31713728 |
| 125 | PRKCG | 0.31597692 |
| 126 | CSNK1A1L | 0.31002574 |
| 127 | CSNK1A1 | 0.30235296 |
| 128 | CSNK1D | 0.27154326 |
| 129 | DAPK1 | 0.26772287 |
| 130 | PLK2 | 0.26439285 |
| 131 | ZAK | 0.25962169 |
| 132 | DYRK1A | 0.25680722 |
| 133 | PRKCI | 0.24240063 |
| 134 | NLK | 0.23793951 |
| 135 | MAPK10 | 0.22973848 |
| 136 | MAPK7 | 0.21415220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.35839087 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.22915983 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.06476790 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.93125687 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.69610600 |
| 6 | * Insulin secretion_Homo sapiens_hsa04911 | 2.40397699 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.33335120 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.08978164 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01498638 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.96286444 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.89046532 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.86632646 |
| 13 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79605975 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.71180438 |
| 15 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.68535356 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65714137 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59095632 |
| 18 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.49951340 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48106717 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42409626 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.42080662 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.41698725 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39643833 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39184395 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38508510 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34268598 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.33075219 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32152080 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.30606966 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28943686 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27493482 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.27418147 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25410909 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.25398251 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24180823 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.23690656 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21908931 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21322907 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.20199135 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18959343 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17752970 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16272970 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15343527 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12417499 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10970805 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10785914 |
| 47 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10765841 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10276822 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.08864509 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.07206996 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07130552 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.06805985 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06682447 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05869357 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04549105 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99818182 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96173691 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95862829 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94896435 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94678881 |
| 61 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93178770 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93096392 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.92597041 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91114343 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89490707 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86673043 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85978068 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84827428 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83959217 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82615323 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82483024 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81553190 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80792591 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80476578 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80222368 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79580676 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.78985336 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76683034 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75946923 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74142744 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.72665929 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71778425 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71570264 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70736640 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.69649476 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68394297 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65001948 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64678074 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64035584 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60402669 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59611831 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58561936 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.58431907 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55707244 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55162850 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.55086054 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54778703 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54002505 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51761233 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48752467 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48588442 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.46329876 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42999075 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41624438 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40623256 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39083577 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.39017282 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38289268 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.37988532 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37436519 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37064146 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.34565536 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34465657 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33873855 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33374104 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33314703 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33029006 |
| 118 | Purine metabolism_Homo sapiens_hsa00230 | 0.32348454 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31265710 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31126317 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30646547 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.29925838 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.29840071 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28498719 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28389624 |

